Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage: The Swiss Study on Subarachnoid Hemorrhage (Swiss SOS).


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 5 12 2020
medline: 20 4 2021
entrez: 4 12 2020
Statut: ppublish

Résumé

The purpose of this study was to assess nationwide incidence and outcomes of aneurysmal subarachnoid hemorrhage (aSAH). The Swiss SOS (Swiss Study on Subarachnoid Hemorrhage) was established in 2008 and offers the unique opportunity to provide this data from the point of care on a nationwide level. All patients with confirmed aneurysmal subarachnoid hemorrhage admitted between January 1, 2009 and December 31, 2014, within Switzerland were recorded in a prospective registry. Incidence rates were calculated based on time-matched population data. Admission parameters and outcomes at discharge and at 1 year were recorded. We recorded data of 1787 consecutive patients. The incidence of aneurysmal subarachnoid hemorrhage in Switzerland was 3.7 per 100 000 persons/y. The number of female patients was 1170 (65.5%). With a follow-up rate of 91.3% at 1 year, 1042 patients (58.8%) led an independent life according to the modified Rankin Scale (0-2). About 1 in 10 patients survived in a dependent state (modified Rankin Scale, 3-5; n=185; 10.4%). Case fatality was 20.1% (n=356) at discharge and 22.1% (n=391) after 1 year. The current incidence of aneurysmal subarachnoid hemorrhage in Switzerland is lower than expected and an indication of a global trend toward decreasing admissions for ruptured intracranial aneurysms. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT03245866.

Sections du résumé

BACKGROUND AND PURPOSE
The purpose of this study was to assess nationwide incidence and outcomes of aneurysmal subarachnoid hemorrhage (aSAH). The Swiss SOS (Swiss Study on Subarachnoid Hemorrhage) was established in 2008 and offers the unique opportunity to provide this data from the point of care on a nationwide level.
METHODS
All patients with confirmed aneurysmal subarachnoid hemorrhage admitted between January 1, 2009 and December 31, 2014, within Switzerland were recorded in a prospective registry. Incidence rates were calculated based on time-matched population data. Admission parameters and outcomes at discharge and at 1 year were recorded.
RESULTS
We recorded data of 1787 consecutive patients. The incidence of aneurysmal subarachnoid hemorrhage in Switzerland was 3.7 per 100 000 persons/y. The number of female patients was 1170 (65.5%). With a follow-up rate of 91.3% at 1 year, 1042 patients (58.8%) led an independent life according to the modified Rankin Scale (0-2). About 1 in 10 patients survived in a dependent state (modified Rankin Scale, 3-5; n=185; 10.4%). Case fatality was 20.1% (n=356) at discharge and 22.1% (n=391) after 1 year.
CONCLUSIONS
The current incidence of aneurysmal subarachnoid hemorrhage in Switzerland is lower than expected and an indication of a global trend toward decreasing admissions for ruptured intracranial aneurysms. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT03245866.

Identifiants

pubmed: 33272133
doi: 10.1161/STROKEAHA.120.029538
doi:

Banques de données

ClinicalTrials.gov
['NCT03245866']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

344-347

Auteurs

Bawarjan Schatlo (B)

Neurosurgery (B.S., A.S., M.C., P.B., K.S.), University Hospital Geneva, Switzerland.
Neurosurgery (B.S., J.F., S.M., D.D., K.W., H.D.U., H.L.), Kantonsspital Aarau Switzerland.
Neurosurgery, University Hospital Göttingen Germany (B.S., V.R.).

Christian Fung (C)

Neurosurgery (C.F., D.B., D. Schöni, J. Goldberg, C.E., J.B., A.R.), University Hospital Bern Switzerland.
Department of Neurosurgery, Faculty of Medicine, Medical Center, University of Freiburg, Germany (J.B., C.F.).

Martin N Stienen (MN)

Neurosurgery (M.N.S., J.-K.B., C.W., N.M., R.B., S.F., L.R.), University Hospital Zürich Switzerland.

Ali R Fathi (AR)

Neurosurgery, Hirslanden Klinik Aarau Switzerland (A.R.F.).

Javier Fandino (J)

Neurosurgery (B.S., J.F., S.M., D.D., K.W., H.D.U., H.L.), Kantonsspital Aarau Switzerland.

Nicolas R Smoll (NR)

School of Population and Global, University of Melbourne Australia (N.R.S.).

Daniel Zumofen (D)

Neurosurgery, University Hospital Basel Switzerland (D.Z., M. Roethlisberger, M. Sailer, L.M., R.G.).

Roy Thomas Daniel (RT)

Neurosurgery, University Hospital Lausanne Switzerland (R.T.D., D. Starnoni, R.M., M.L.).

Jan-Karl Burkhardt (JK)

Neurosurgery (M.N.S., J.-K.B., C.W., N.M., R.B., S.F., L.R.), University Hospital Zürich Switzerland.

David Bervini (D)

Neurosurgery (C.F., D.B., D. Schöni, J. Goldberg, C.E., J.B., A.R.), University Hospital Bern Switzerland.

Serge Marbacher (S)

Neurosurgery (B.S., J.F., S.M., D.D., K.W., H.D.U., H.L.), Kantonsspital Aarau Switzerland.

Michael Reinert (M)

Neurosurgery, Ospedale Civico Lugano Switzerland (M. Reinert, A.V., T.R.).

Donato D Alonzo (D)

Neurosurgery (B.S., J.F., S.M., D.D., K.W., H.D.U., H.L.), Kantonsspital Aarau Switzerland.

Peter Ahlborn (P)

Neurosurgery, Kantonsspital St. Gallen Switzerland (P.A., M. Seule, A.W., A.F., G.H.).

Vitor Mendes Pereira (V)

Neuroradiology, University of Toronto Canada (V.M.P.).

Michel Roethlisberger (M)

Neurosurgery, University Hospital Basel Switzerland (D.Z., M. Roethlisberger, M. Sailer, L.M., R.G.).

Martin Seule (M)

Neurosurgery, Kantonsspital St. Gallen Switzerland (P.A., M. Seule, A.W., A.F., G.H.).

Hassen Kerkeni (H)

Neurology (H.K.), Kantonsspital Aarau Switzerland.

Luca Remonda (L)

Neuroradiology (L.R., M.D.), Kantonsspital Aarau Switzerland.

Astrid Weyerbrock (A)

Neurosurgery, Kantonsspital St. Gallen Switzerland (P.A., M. Seule, A.W., A.F., G.H.).

Kerstin Woernle (K)

Neurosurgery (B.S., J.F., S.M., D.D., K.W., H.D.U., H.L.), Kantonsspital Aarau Switzerland.

Alice Venier (A)

Neurosurgery, Ospedale Civico Lugano Switzerland (M. Reinert, A.V., T.R.).

Fabienne Perren (F)

Neurology (F.P.), University Hospital Geneva, Switzerland.

Martin Sailer (M)

Neurosurgery, University Hospital Basel Switzerland (D.Z., M. Roethlisberger, M. Sailer, L.M., R.G.).

Thomas Robert (T)

Neurosurgery, Ospedale Civico Lugano Switzerland (M. Reinert, A.V., T.R.).

Veit Rohde (V)

Neurosurgery, University Hospital Göttingen Germany (B.S., V.R.).

Daniel Schöni (D)

Neurosurgery (C.F., D.B., D. Schöni, J. Goldberg, C.E., J.B., A.R.), University Hospital Bern Switzerland.

Johannes Goldberg (J)

Neurosurgery (C.F., D.B., D. Schöni, J. Goldberg, C.E., J.B., A.R.), University Hospital Bern Switzerland.

Edin Nevzati (E)

Neurosurgery, Kantonsspital Luzern Switzerland (E.N., F.B.).

Michael Diepers (M)

Neuroradiology (L.R., M.D.), Kantonsspital Aarau Switzerland.

Jan Gralla (J)

Neuroradiology (J. Gralla, W.Z.), University Hospital Bern Switzerland.

Werner Z'Graggen (W)

Neuroradiology (J. Gralla, W.Z.), University Hospital Bern Switzerland.

Daniele Starnoni (D)

Neurosurgery, University Hospital Lausanne Switzerland (R.T.D., D. Starnoni, R.M., M.L.).

Christoph Woernle (C)

Neurosurgery (M.N.S., J.-K.B., C.W., N.M., R.B., S.F., L.R.), University Hospital Zürich Switzerland.

Nicolai Maldaner (N)

Neurosurgery (M.N.S., J.-K.B., C.W., N.M., R.B., S.F., L.R.), University Hospital Zürich Switzerland.

Zsolt Kulcsar (Z)

Department of Neuroradiology, University Hospital Zürich, Switzerland (Z.K.).

Khaled Mostaguir (K)

Clinical Research Centre, (K.M.), University Hospital Geneva, Switzerland.

Rodolfo Maduri (R)

Neurosurgery, University Hospital Lausanne Switzerland (R.T.D., D. Starnoni, R.M., M.L.).

Christian Eisenring (C)

Neurosurgery (C.F., D.B., D. Schöni, J. Goldberg, C.E., J.B., A.R.), University Hospital Bern Switzerland.

René Bernays (R)

Neurosurgery (M.N.S., J.-K.B., C.W., N.M., R.B., S.F., L.R.), University Hospital Zürich Switzerland.

Andrea Ferrari (A)

Neurosurgery, Kantonsspital St. Gallen Switzerland (P.A., M. Seule, A.W., A.F., G.H.).

Hiroki Dan-Ura (H)

Neurosurgery (B.S., J.F., S.M., D.D., K.W., H.D.U., H.L.), Kantonsspital Aarau Switzerland.

Sina Finkenstädt (S)

Neurosurgery (M.N.S., J.-K.B., C.W., N.M., R.B., S.F., L.R.), University Hospital Zürich Switzerland.

Yvan Gasche (Y)

Intensive Care Medicine (Y.G.), University Hospital Geneva, Switzerland.

Asita Sarrafzadeh (A)

Neurosurgery (B.S., A.S., M.C., P.B., K.S.), University Hospital Geneva, Switzerland.

Stephan M Jakob (SM)

Intensive Care Medicine (S.M.J.), University Hospital Bern Switzerland.

Marco Corniola (M)

Neurosurgery (B.S., A.S., M.C., P.B., K.S.), University Hospital Geneva, Switzerland.

Fabian Baumann (F)

Neurosurgery, Kantonsspital Luzern Switzerland (E.N., F.B.).

Luca Regli (L)

Neurosurgery (M.N.S., J.-K.B., C.W., N.M., R.B., S.F., L.R.), University Hospital Zürich Switzerland.

Marc Levivier (M)

Neurosurgery, University Hospital Lausanne Switzerland (R.T.D., D. Starnoni, R.M., M.L.).

Gerhard Hildebrandt (G)

Neurosurgery, Kantonsspital St. Gallen Switzerland (P.A., M. Seule, A.W., A.F., G.H.).

Hans Landolt (H)

Neurosurgery (B.S., J.F., S.M., D.D., K.W., H.D.U., H.L.), Kantonsspital Aarau Switzerland.

Luigi Mariani (L)

Neurosurgery, University Hospital Basel Switzerland (D.Z., M. Roethlisberger, M. Sailer, L.M., R.G.).

Raphael Guzman (R)

Neurosurgery, University Hospital Basel Switzerland (D.Z., M. Roethlisberger, M. Sailer, L.M., R.G.).

Jürgen Beck (J)

Neurosurgery (C.F., D.B., D. Schöni, J. Goldberg, C.E., J.B., A.R.), University Hospital Bern Switzerland.
Department of Neurosurgery, Faculty of Medicine, Medical Center, University of Freiburg, Germany (J.B., C.F.).

Andreas Raabe (A)

Neurosurgery (C.F., D.B., D. Schöni, J. Goldberg, C.E., J.B., A.R.), University Hospital Bern Switzerland.

Emanuela Keller (E)

Intensive Care Medicine (E.K.), University Hospital Zürich Switzerland.

Philippe Bijlenga (P)

Neurosurgery (B.S., A.S., M.C., P.B., K.S.), University Hospital Geneva, Switzerland.

Karl Schaller (K)

Neurosurgery (B.S., A.S., M.C., P.B., K.S.), University Hospital Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH